Zhang, G

Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study. [electronic resource] - The British journal of dermatology 05 2018 - 1213-1214 p. digital

Publication Type: Letter

1365-2133

10.1111/bjd.16400 doi


Antineoplastic Agents--administration & dosage
Drug Administration Schedule
Hemangioendothelioma--drug therapy
Humans
Infant
Kasabach-Merritt Syndrome--drug therapy
Retrospective Studies
Sarcoma, Kaposi--drug therapy
Sirolimus--administration & dosage
Treatment Outcome
Vascular Neoplasms--drug therapy